Neoantigen Peptide Synthesis|Kev cai Neoantigen Peptide|qog immunotherapy|Kev tshawb fawb-Peptide

 

Meta Description

 

Xav tau Neoantigen Peptide rau cov tshuaj tiv thaiv qog nqaij hlav lossis T-kev tshawb fawb ntawm tes? Kev tshawb fawb-Peptide muab kev pabcuam Neoantigen Peptide synthesis nrog kev ua siab dawb huv, xa khoom sai, thiab kev txhawb nqa rau ntau yam kev hloov kho los pab txhawb kev txhim kho kev tiv thaiv tus kheej. Thov koj xav tiv tauj peb.

 

Neoantigen Peptide: ib qho tseem ceeb ntawm cov puzzle rau tus kheej immunotherapy uas

 

Vim li cas Neoantigen Peptide thiaj li kub?
Cov neeg uas ua cov qog tiv thaiv kab mob paub tias neoantigen yog cov khoom hloov pauv tshwj xeeb rau cov qog hlwb, uas tsis muaj nyob hauv cov hlwb li qub. Ua kom T-cells nrog neoantigens tuaj yeem tua cov qog thiab yuav tsis ua mob rau cov neeg dawb huv. Yog li ntawd, txawm nws yog tshuaj tiv thaiv qog los yog TCR-T kho, txhua tus tab tom nrhiav neoantigen.

Tab sis mus tom qab ib qho antigen tshiab, koj thawj zaug yuav tsum tau txais cov peptide. Qhov ntawd yog qhov peb ua - Neoantigen Peptide Synthesis.

page-800-600

 

Neoantigen Peptide kawm, dab tsi ua rau koj mob taub hau?

 

Peb tau tham nrog ntau pab pawg txhaj tshuaj thiab pom tias muaj ntau qhov mob tshwm sim:


Muaj ntau tus neeg sib tw peptides:tus neeg mob yuav raug tshuaj xyuas rau kaum ob lossis ntau pua qhov chaw hloov pauv, txhua qhov yuav tsum tau ua ke thiab sim, thiab kev ua haujlwm loj heev.
Peptide Length:Neoantigen Peptide feem ntau yog 15-25 amino acids, uas ntev dua li ib txwm luv peptide, thiab nws nyuaj rau kev sib txuas.
Lub sijhawm ua haujlwm ntev:Tos rau peptides yuav siv sij hawm ntev dua qhov kev sim, thiab qhov kev ua tiav ntawm qhov project yog rub nrog.
Tsis txaus purity:Kev sim ntawm tes yuav tsum tau purity, thiab cov txiaj ntsig tsis tuaj yeem nyeem tau yog tias muaj ntau dhau impurities.
Labeling yog yuav tsum tau:Qee zaum nws yog qhov tsim nyog los txuas biotin thiab fluorescent pawg, uas tsis tuaj yeem ua los ntawm cov tuam txhab synthesis zoo tib yam.
Peb qhov kev pabcuam Neoantigen Peptide synthesis tuaj yeem ua rau cov teeb meem no.

 

Peb yuav ua li cas

 

1. Siab -throughput synthesis, ob peb puas ntawm ib zaug
Lub sijhawm tshuaj ntsuam yog ceev. Peb muaj ob peb yam tsis siv neeg synthesizers thiab parallel synthesis systems, uas muaj peev xwm ua ke kaum mus rau pua pua peptides nyob rau hauv ib batch.

  • Cov kev xav tau ntau: cov tsev qiv ntawv antigen tshiab ntawm 96 peptides, xa hauv 2-3 lub lis piam.
  • Flexible batching: ib pawg tuaj yeem xa ua ntej los pib qhov kev sim, thiab tus so tuaj yeem ua tiav.

 

2.Purity ntawm kev thov, los ntawm crude mus rau ultra- ntshiab
Cov kev xav tau rau purity txawv nyob ntawm theem ntawm kev sim:

Qib purity

Siv tau Scenarios

Kev piav qhia

Crude (70-85%)

Kev tshuaj ntsuam thawj zaug, saib seb cov twg yog active

Tus nqi tsawg, kev hloov pauv sai

Cov pa ntshiab (85-95%)

Feem ntau ntawm cov cellular sim ntawd

Tus nqi -zoo, tswj tau impurities

Siab purity (95-98%)

Tsiaj thwmsim, functional validation

Tsawg cuam tshuam thiab txhim khu kev qha

Ultrapure (>98%)

kev kawm txog cov qauv, tshwj xeeb cov kev cai

Ntshiab, me ntsis kim dua

 

Txhua Neoantigen Peptide los nrog HPLC thiab MS daim ntawv qhia, qhov purity yog dab tsi, tsis muaj tseeb.

 

3. Kev hloov kho ntawm Neoantigen Peptide
Qee qhov kev sim xav kom peptide muaj "kev ua haujlwm":

  • Biotin cov cim: ua affinity capture, tetramerization.
  • Fluorescent labeling: FITC, TAMRA, Cy5, saib seb peptide nkag mus rau hauv lub cell li cas.
  • Phosphorylation hloov kho: ua raws li kev tshaj tawm -txoj kev txhais lus.
  • PEGylation: ncua ib nrab -lub neej, rau hauv vivo kev sim.
  • Stapled peptide: Stabilizes conformation thiab txhim kho immunogenicity.

 

Vim li cas thiaj xaiv peb rau Neoantigen Peptide?

 

1. Kuv tau ua peptides tau 20 xyoo, thiab kuv tau pom txhua yam nyuaj
Neoantigen Peptide suab tshiab, tab sis nws yog qhov tseem ceeb peptide synthesis. Hydrophobic peptides, peptides uas yooj yim aggregated, peptides nrog disulfide bonds, peptides uas yuav tsum tau hloov kho tshwj xeeb - peb tau lis ntau nyuaj peptides nyob rau hauv 20 xyoo dhau los. Yog li ntawd, peb yuav pab koj kom tsis txhob muaj qhov cuam tshuam ntawm Neoantigen Peptide ua ntej.

 

2. High flux, kuj ceev
Qee cov neeg siv khoom txhawj xeeb tias yog tias lawv xaj ntau lub peptides ib zaug, puas yuav ncua sijhawm ntev? Peb muaj peb tus kheej cov txheej txheem, synthesis, purification, kev tswj kom zoo yog tag nrho cov du, 96 peptides ntawm cov qauv tsev qiv ntawv, 2-3 lub lis piam kom tiav, nyob rau hauv nruab nrab ntawm qhov xav tau rau koj maj. Yog tias muaj qhov project ceev, peb tuaj yeem xa hauv cov khoom siv, kom koj tuaj yeem sawv thiab khiav ua ntej.

 

3. Kev tswj xyuas zoo tsis yog dag ib puag ncig, thiab txhua tus peptide tau sau tseg
Dab tsi yog qhov kev ntshai loj tshaj plaws ntawm kev tshawb fawb antigen tshiab? Tsis yog peptide ib ntus lossis impurities cuam tshuam nrog cov txiaj ntsig kev sim. Peb hais:
MS tau ua tiav rau txhua peptide kom paub meej tias qhov hnyav molecular yog qhov tseeb.
Txhua peptide tau raug rau HPLC thiab sau nrog tus nqi ntawm purity.
Tag nrho cov ntaub ntawv yog muab nrog cov khoom xa tuaj thiab yuav pab tau thaum koj tshaj tawm cov khoom.

 

4. Ua raws li los ntawm kev tshuaj ntsuam mus rau preclinical
Muaj ob peb theem ntawm kev tshawb fawb neoantigen, tag nrho cov uas peb tuaj yeem khaws:
Lub sij hawm tshuaj ntsuam: coob tus neeg sib tw peptides, crude los yog conventionally ntshiab, xa sai.
Validation theem: ob peb qhov zoo raug tshuaj xyuas, yuav tsum muaj siab purity rau kev soj ntsuam ntawm tes.
Preclinical: Ntsuas txog li milligrams lossis txawm tias grams thiab ua cov kev tshawb fawb tsiaj.
Tsis tas yuav hloov cov neeg xa khoom rau tib qhov project, tshem tawm cov nqi ntawm kev sib tshuam.

 

Qhov twg tuaj yeem siv Neoantigen Peptide?

 

Tshawb nrhiav cov lus qhia

Cov kev xav tau

Peb qhov kev pab cuam

cov tshuaj tiv thaiv qog nqaij hlav

Ntev peptides ntawm 15-25 amino acids

High -throughput synthesis, xa ceev ceev ntawm cov tsev qiv ntawv sib tw

T-kev tshuaj ntsuam ntawm tes

MHC-binding luv peptide (8-11aa)

Precision synthesized, purity >95%

TCR{0}}T cell therapy

kev paub tshwj xeeb ntawm peptides

Tej zaum yuav tau sau npe rau kev kuaj affinity

Kev tshuaj xyuas kev txhaj tshuaj

paub lub tsev qiv ntawv epitope peptide

Batch synthesis, batch zoo ib yam

kev kawm txog cov qauv

Hloov pauv peptides (phosphorylated, biotin)

Precision site hloov kho, MS / MS validation

 

Kev xa khoom thiab kev tswj xyuas zoo

 

Kev xa tawm format:lyophilized hmoov, ntim rau hauv 96-zoo daim hlau los yog ib tus neeg centrifuge raj, code traceable.
Cov ntaub ntawv nrog:COA (HPLC profile + MS profile) rau txhua peptide.
Optional xeem:MS/MS Secondary Mass spectrometry, peptide cov ntsiab lus, endotoxin, noo noo.
Customized Ntim:Dispensing, labeling, mixing as per tus neeg yuav tsum tau muaj.

page-800-1067
page-800-1067
page-800-1067

 

Peb lub neej tiag tiag - piv txwv li cas peb pab peb cov neeg siv khoom

 

Case 1: Lub teb chaws sab saum toj oncology lub koom haum

The customer needed 120 Neoantigen Peptides of 15-20 amino acids for personalized vaccine screening. We delivered all of them in 2.5 weeks with purity >90%. Lawv tau tshuaj xyuas 5 qhov zoo nrog cov peptides no, thiab ua raws li- ua haujlwm tau tshaj tawm hauv Nature.

Case 2: American Biotechnology Corporation

They needed a batch of biotin-labeled MHC-peptide complex for TCR-T. We synthesized the high-purity peptide according to the sequence and completed the labeling. We synthesized the high-purity peptide according to the sequence and completed the labeling, the labeling efficiency was >95%.

Case 3: Preclinical Programs ntawm European Pharmaceutical Companies

The client has sieved 3 Neoantigen Peptides, which need to be scaled up to 500mg for animal experiments. These three peptides are highly hydrophobic and difficult to synthesize. We optimized the solvent system and finally delivered >95% purity thiab 20% siab tshaj tawm los tshaj qhov lawv xav tau.

 

Tam sim no, koj xav tau Neoantigen Peptide li cas?

 

Txawm hais tias koj nyuam qhuav pib tshuaj ntsuam peptide cov neeg sib tw los yog twb nyob rau theem validation, peb muaj cov kev pab cuam synthesis rau koj.

 

Qhov peb xav tau koj qhia peb:
Cov npe Peptide ua ntu zus (Excel hom ntawv zoo tshaj)
Tus nqi xav tau rau ib qho peptide (mg)
purity xav tau
Seb puas yuav tsum tau hloov kho
lub sij hawm xa tuaj

 

Muab koj cov lus qhia txhim khu kev qha thiab kev npaj xa tuaj hauv 24 teev.

 

page-500-500

Neoantigen Peptides rau Cancer Immunotherapy

 

page-500-500

Kev Tshawb Fawb Qib Neoantigen

 

page-500-500

GMP Neoantigen